Justin J Noznesky Atri Cure, Inc. (ATRC) insider trading activity

Justin J Noznesky is Chief Mktg & Strategy Officer of AtriCure, Inc.. Currently has a direct ownership of 86,964 shares of ATRC, which is worth approximately $2.77 Million. The most recent transaction as insider was on Mar 01, 2025, when has been sold 9,673 shares (Common Stock) at a price of $38.74 per share, resulting in proceeds of $374,732. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 87K

23.01% 3M change

17.07% 12M change

Total Value Held $2.77 Million

Justin J Noznesky Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2025	SELL Payment of exercise price or tax liability	$374,732 $38.74 p/Share	9,673 Reduced 10.01%	86,964 Common Stock
Mar 01 2025	BUY Grant, award, or other acquisition	-	25,938 Added 21.16%	96,637 Common Stock
Dec 11 2024	SELL Bona fide gift	-	585 Reduced 0.82%	70,699 Common Stock
May 01 2024	SELL Open market or private sale	$36,135 $24.09 p/Share	1,500 Reduced 2.06%	71,284 Common Stock
Apr 01 2024	SELL Open market or private sale	$45,585 $30.39 p/Share	1,500 Reduced 2.02%	72,784 Common Stock
Mar 12 2024	SELL Open market or private sale	$55,080 $36.72 p/Share	1,500 Reduced 1.98%	74,284 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$321,295 $36.28 p/Share	8,856 Reduced 10.46%	75,784 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	28,622 Added 25.27%	84,640 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	$20,846 $38.11 p/Share	547 Added 0.97%	56,018 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$274,891 $38.81 p/Share	7,083 Reduced 11.32%	55,471 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	24,140 Added 27.85%	62,554 Common Stock
Dec 30 2022	BUY Grant, award, or other acquisition	$20,393 $34.86 p/Share	585 Added 1.5%	38,414 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$520,116 $69.59 p/Share	7,474 Reduced 16.5%	37,829 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	14,614 Added 24.39%	45,303 Common Stock
Jun 25 2021	SELL Open market or private sale	$329,520 $80.0 p/Share	4,119 Reduced 11.83%	30,689 Common Stock
Jun 21 2021	SELL Open market or private sale	$1,603,560 $76.36 p/Share	21,000 Reduced 37.63%	34,808 Common Stock
Jun 21 2021	BUY Exercise of conversion of derivative security	$274,500 $18.3 p/Share	15,000 Added 21.18%	55,808 Common Stock
May 05 2021	SELL Bona fide gift	-	2,300 Reduced 5.34%	40,808 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$917,730 $66.31 p/Share	13,840 Reduced 24.3%	43,108 Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	14,340 Added 20.12%	56,948 Common Stock
Jan 04 2021	SELL Open market or private sale	$1,253,845 $53.59 p/Share	23,397 Reduced 35.45%	42,608 Common Stock
Jan 04 2021	BUY Exercise of conversion of derivative security	$274,500 $18.3 p/Share	15,000 Added 18.52%	66,005 Common Stock
Nov 10 2020	SELL Bona fide gift	-	250 Reduced 0.49%	51,005 Common Stock

JJN

Justin J Noznesky

Chief Mktg & Strategy Officer

Mason, OH

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRC shares.

Notify only if

Value

Insider Trading

Get notified when an Atri Cure, Inc. insider buys or sells ATRC shares.

Notify only if

Operation

Value

Type

News

Receive news related to AtriCure, Inc.

Track Activities on ATRC

Account